Moreover, methylation levels of CpG4.3 were tightly associated with SSTR5 and SSTR5‐AS1 expression in somatotropinomas, where lower levels of methylation were linked to higher expression of these genes, but not in NP samples. This evidence concerns the gene SSTR5 and growth hormone-producing pituitary gland neoplasm.